{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "3CLpro",
      "COVID-19",
      "NO/cGMP",
      "PDE5",
      "PDE5 inhibitors",
      "SARS-CoV-2",
      "sildenafil",
      "tadalafil",
      "thromboembolism"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33576273",
  "DateCompleted": {
    "Year": "2021",
    "Month": "10",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "10"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "02",
        "Day": "12"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.2217/fca-2020-0201"
    ],
    "Journal": {
      "ISSN": "1744-8298",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "5",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug"
        }
      },
      "Title": "Future cardiology",
      "ISOAbbreviation": "Future Cardiol"
    },
    "ArticleTitle": "Targeting the SARS-CoV-2 3CL<sup>pro</sup>\u00a0and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors.",
    "Pagination": {
      "StartPage": "765",
      "EndPage": "768",
      "MedlinePgn": "765-768"
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-5122-1274"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."
          },
          {
            "Identifier": [],
            "Affiliation": "Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran."
          }
        ],
        "LastName": "Shirvaliloo",
        "ForeName": "Milad",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Editorial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Future Cardiol",
    "NlmUniqueID": "101239345",
    "ISSNLinking": "1479-6678"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Phosphodiesterase 5 Inhibitors"
    },
    {
      "RegistryNumber": "H2D2X058MU",
      "NameOfSubstance": "Cyclic GMP"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Cyclic GMP"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Phosphodiesterase 5 Inhibitors"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}